New research suggests that analyzing genetic data from healthy tissue close to lung tumors may be a better predictor of cancer recurrence after treatment than analyzing the tumors themselves. The study found that analyzing RNA from apparently healthy tissue accurately predicted cancer recurrence 83% of the time, compared to 63% accuracy when analyzing RNA from tumors. The findings indicate that the pattern of gene expression in healthy tissue could serve as a biomarker for predicting lung cancer recurrence in its earliest stages.
टिप्पणियाँ
एक टिप्पणी भेजें